Chris shares intriguing results from an epigenetic test conducted on a family member in his seventies after using Novos. While he refrains from disclosing specific numbers, the significant improvement in epigenetic age suggests a promising impact of the formulations. His personal experiences lead him to believe that the positive outcomes he’s experiencing may largely stem from Novos.
